Five Key Takeaways From the Public Healthcare Operators in 2021
February 9, 2022
The defensive measures that the federal and local governments have taken to combat the rapid progression of the Coronavirus Disease (“COVID-19”) in the United States has had a significant impact on diagnostic imaging centers (“Imaging Centers”), along with every sub-sector within the healthcare industry. This article shares VMG Health’s outlook on both short and long-term operational risks facing Imaging Centers and addresses how these factors may affect impending valuations. It should be noted that this is a very fluid time and viewpoints can quickly become antiquated.
First, it is important to consider the relevant published guidance regarding prioritizing medical care. On March 18th, the Centers for Medicare & Medicaid Services (“CMS”) announced at the White House Task Force Press Briefing, “all elective surgeries, non-essential medical, surgical, and dental procedures be delayed during the 2020 Novel Coronavirus (COVID-19) outbreak” consistent with Centers for Disease Control and Prevention (“CDC”) guidelines. CMS proposed a tiered framework to prioritize care and to protect against further spread of the virus. Subsequently, the American College of Radiology (“ACR”) published guidance related to COVID-19. Per the guidance, “The ACR fully supports and recommends compliance with the Centers for Disease Control and Prevention guidance that advises medical facilities to “reschedule non-urgent outpatient visits.” This includes non-urgent imaging and fluoroscopy procedures, including but not limited to: screening mammography, lung cancer screening, computed tomography (CT), ultrasound, plain film X-ray exams, magnetic resonance imaging (MRI) and other non-emergent or elective radiologic and radiologically guided exams and procedures. Radiologists should work with their referring physicians to review and reschedule such exams.” We have seen this guidance play-out real-time with our Imaging Center clients as many had already begun rescheduling truly elective procedures and performing medically necessary/urgent procedures only. On April 16th, the White House released guidelines for “Opening Up America Again.” Based on the guidance provided, this will be a three phased approach whereby if certain gating criteria are met by states and regions, they can begin to open up the healthcare industry to elective scans. The first phase will include opening up outpatient facilities while phase two will be to open up inpatient facilities.
Imaging Centers have long been desirable for radiologists, health system, and corporate investors because they tend to generate consistent cash flows and distributions. In addition, increased payor pressure, pricing transparency, and CMS guidelines have created a shift in volume from hospital-based imaging to truly freestanding imaging centers. It is important now more than ever for valuation firms to be diligent when examining the historical and future operations of an imaging center with management because these discussions will be invaluable in analyzing the probability of projected outcomes. While undertaking a valuation during this pandemic can prove challenging due to the uncertainty, cash flow and risk of achieving the projections can be appropriately managed in the short and long-term to derive a value that is reflective of these challenging times.
As it relates to expected cash flow generation and related projection risk, COVID-19 will undoubtedly impact both. Although expected cash flow and projection risk are related, we will address them separately starting with the impact to cash flow:
In addition to more discrete, quantifiable impacts to value, unknown risks exist that present challenges to projecting distinct financial and operational forecasts. The immeasurable risk factors that affect value include:
These immeasurable risk factors are best accounted for in the discount rate as a valuation expert will be unable to discretely capture the inherent risk in the projected cash flows. Given the extent of these uncertainties, the risk profile of an Imaging Center investment at the present time should be considered elevated.
As the pandemic continues to unfold and federal and local policies change, COVID-19 will undoubtedly continue to impact the short-term and long-term operations of an Imaging Center. The COVID-19 impact will not be identical for all Imaging Centers due to specific risk factors, geographical market dynamics, and the respective valuation date. Therefore, determining the known or knowable COVID-19 facts and circumstances as of the valuation date as well as examining the probability of short and long-term risks with management will be the foundation to appropriately projecting an investor’s future returns.